Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
-
- Maria P. Limberis
- Gene Therapy Program, University of Pennsylvania, Philadelphia, PA 19104, USA.
-
- Virginie S. Adam
- Gene Therapy Program, University of Pennsylvania, Philadelphia, PA 19104, USA.
-
- Gary Wong
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
-
- Jason Gren
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
-
- Darwyn Kobasa
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
-
- Ted M. Ross
- Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA 15261, USA.
-
- Gary P. Kobinger
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
-
- Anna Tretiakova
- Gene Therapy Program, University of Pennsylvania, Philadelphia, PA 19104, USA.
-
- James M. Wilson
- Gene Therapy Program, University of Pennsylvania, Philadelphia, PA 19104, USA.
書誌事項
- 公開日
- 2013-05-29
- DOI
-
- 10.1126/scitranslmed.3006299
- 公開者
- American Association for the Advancement of Science (AAAS)
この論文をさがす
説明
<jats:p>Intranasal delivery of a broadly neutralizing antibody to influenza by an AAV9 vector affords complete protection.</jats:p>
収録刊行物
-
- Science Translational Medicine
-
Science Translational Medicine 5 (187), 187ra172-, 2013-05-29
American Association for the Advancement of Science (AAAS)